首页 › 基金 › Invenomic Capital Management LP › NICE

Invenomic Capital Management LP 对 NICE 的持仓历史

NICE LTD · 科技

Invenomic Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 NICE(NICE LTD)233,366 股,市值约 US$26.0M,约占其申报组合的 1.28%,在其申报持仓中市值排名第 30 位。 Invenomic Capital Management LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)233.37K 股
申报持仓市值$25.97M
组合权重1.28%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Invenomic Capital Management LP 对 NICE 的持仓演变

Invenomic Capital Management LP 于 Q3 2026 首次披露 NICE 持仓:233,366 股(约 US$26.0M)。

逐季持仓明细

季度股数金额变化
Q3 2026 233.37K $25.97M 新进

关于 NICE 与 13F 数据

NICE(NICE LTD)属于科技行业。我们追踪的基金中还有 11 只申报持有 NICE,申报仓位最大的包括:BRANDES INVESTMENT PARTNERS, LP (US$323.7M), HARDING LOEVNER LP (US$217.1M), Clal Insurance Enterprises Holdings Ltd (US$173.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NICE 的基金

查看 NICE 的全部基金持有人 →

常见问题

How long has Invenomic Capital Management LP held NICE?

Invenomic Capital Management LP has disclosed NICE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Invenomic Capital Management LP's current position in NICE?

As of Q3 2026, Invenomic Capital Management LP holds 233.37K shares of NICE (NICE LTD), valued at $25.97M, representing 1.28% of its reported portfolio and ranking #30.

Has Invenomic Capital Management LP been buying or selling NICE?

In the latest 13F filing (Q3 2026), Invenomic Capital Management LP newly opened its position in NICE.

Which other funds hold NICE?

Other major institutional holders of NICE include BRANDES INVESTMENT PARTNERS, LP, HARDING LOEVNER LP, Clal Insurance Enterprises Holdings Ltd, among 11 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.